UTHR

United Therapeutics Corporation (UTHR)

Last Price$365.0(0.4%)
Market Cap$16.2B
LTM P/E
14.6x
EPS growth
17.5%
PEGY
0.8x
Peter Lynch Fair Value
$438.0
Undervalued (Peter Lynch formula)
20.0%
Stock quality
8/10
Great

UTHR Peter Lynch Fair Value

Crunching data... Almost there!

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

UTHR EPS growth & Dividend Yield

Crunching data... Almost there!

UTHR vs Peer Set: Peter Lynch Fair Value Comparison

Crunching data... Almost there!

Explore more intrinsic value tools hub for UTHR

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

What is United Therapeutics Corporation fair value by Peter Lynch formula?

As of Jan 10, 2025, United Therapeutics Corporation's fair value using the Peter Lynch formula is $438.0 per share. The current price of $365.0 suggests United Therapeutics Corporation may be undervalued by this metric.

What is United Therapeutics Corporation Price to Earnings (P/E) ratio?

As of Jan 10, 2025, United Therapeutics Corporation's P/E ratio is 14.6x. This is calculated by dividing the current share price of $365.0 by the Earnings per Share (EPS) for the trailing twelve months, which is $24.3. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.

What is United Therapeutics Corporation earnings per share (EPS)?

United Therapeutics Corporation earnings per share (EPS) for the twelve months ending Jan 10, 2025, was $24.3, a 17.5% growth year-over-year.